Grobben M, Bakker M, Schriek A, Levels L, Umotoy J, Tejjani K
PLoS Pathog. 2024; 20(12):e1012739.
PMID: 39661636
PMC: 11634010.
DOI: 10.1371/journal.ppat.1012739.
Kalinichenko S, Ramadan L, Kruglova N, Balagurov K, Lukashina M, Mazurov D
Biology (Basel). 2024; 13(9).
PMID: 39336102
PMC: 11428423.
DOI: 10.3390/biology13090675.
Ortiz Y, Anasti K, Kane A, Cronin K, Alam S, Reth M
Proc Natl Acad Sci U S A. 2024; 121(31):e2404728121.
PMID: 39042672
PMC: 11295018.
DOI: 10.1073/pnas.2404728121.
Mao A, Chen X, Zhao W, Nan W, Huang Y, Sun Y
Animals (Basel). 2024; 14(9).
PMID: 38731261
PMC: 11083006.
DOI: 10.3390/ani14091257.
Izadi A, Karami Y, Bratanis E, Wrighton S, Khakzad H, Nyblom M
Nat Commun. 2024; 15(1):3600.
PMID: 38678029
PMC: 11055898.
DOI: 10.1038/s41467-024-47928-8.
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.
Izadi S, Gumpelmair S, Coelho P, Duarte H, Gomes J, Leitner J
Plant Biotechnol J. 2023; 22(5):1224-1237.
PMID: 38050338
PMC: 11022803.
DOI: 10.1111/pbi.14260.
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.
Ormundo L, Barreto C, Tsuruta L
Viruses. 2023; 15(11).
PMID: 38005854
PMC: 10675117.
DOI: 10.3390/v15112177.
Expanding the Anti-Phl p 7 Antibody Toolkit: An Anti-Idiotype Nanobody Inhibitor.
Vester S, Davies A, Beavil R, Sandhar B, Beavil A, Gould H
Antibodies (Basel). 2023; 12(4).
PMID: 37987253
PMC: 10660547.
DOI: 10.3390/antib12040075.
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines.
Fernandez-Quintero M, Pomarici N, Fischer A, Hoerschinger V, Kroell K, Riccabona J
Antibodies (Basel). 2023; 12(4).
PMID: 37873864
PMC: 10594513.
DOI: 10.3390/antib12040067.
Massively-multiplexed epitope mapping techniques for viral antigen discovery.
Hu D, Irving A
Front Immunol. 2023; 14:1192385.
PMID: 37818363
PMC: 10561112.
DOI: 10.3389/fimmu.2023.1192385.
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
Bolton M, Santos J, Arevalo C, Griesman T, Watson M, Li S
Proc Natl Acad Sci U S A. 2023; 120(35):e2216521120.
PMID: 37603748
PMC: 10469028.
DOI: 10.1073/pnas.2216521120.
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies.
Shah A, Chaudhary S, Lakshmanan I, Aithal A, Kisling S, Sorrell C
NPJ Precis Oncol. 2023; 7(1):74.
PMID: 37567918
PMC: 10421872.
DOI: 10.1038/s41698-023-00423-7.
Some structural features of the peptide profile of myelin basic protein-hydrolyzing antibodies in schizophrenic patients.
Zavialova M, Kamaeva D, Kazieva L, Skvortsov V, Smirnova L
PeerJ. 2023; 11:e15584.
PMID: 37431466
PMC: 10329820.
DOI: 10.7717/peerj.15584.
Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG.
Crowley A, Mehlenbacher M, Sajadi M, DeVico A, Lewis G, Ackerman M
MAbs. 2023; 15(1):2231128.
PMID: 37405954
PMC: 10324447.
DOI: 10.1080/19420862.2023.2231128.
Molecular Farming of Pembrolizumab and Nivolumab.
Stark M, Joubert A, Visagie M
Int J Mol Sci. 2023; 24(12).
PMID: 37373192
PMC: 10298108.
DOI: 10.3390/ijms241210045.
The validation of artificial anti-monkeypox antibodies by in silico and experimental approaches.
Shabani S, Rashidi M, Radgoudarzi S, Jebali A
Immun Inflamm Dis. 2023; 11(4):e834.
PMID: 37102640
PMC: 10091375.
DOI: 10.1002/iid3.834.
FLAIRR-Seq: A Method for Single-Molecule Resolution of Near Full-Length Antibody H Chain Repertoires.
Ford E, Tieri D, Rodriguez O, Francoeur N, Soto J, Kos J
J Immunol. 2023; 210(10):1607-1619.
PMID: 37027017
PMC: 10152037.
DOI: 10.4049/jimmunol.2200825.
Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.
Izadi A, Hailu A, Godzwon M, Wrighton S, Olofsson B, Schmidt T
Proc Natl Acad Sci U S A. 2023; 120(15):e2217590120.
PMID: 37011197
PMC: 10104557.
DOI: 10.1073/pnas.2217590120.
Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies.
Moore K, Sengupta U, Puangmalai N, Bhatt N, Kayed R
Mol Neurobiol. 2023; 60(5):2691-2705.
PMID: 36707462
PMC: 9883140.
DOI: 10.1007/s12035-023-03211-3.
Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies.
Malisheni M, Chong C, Murali T, Purushotorman K, Qian X, Laiman A
Pathogens. 2023; 12(1).
PMID: 36678399
PMC: 9865026.
DOI: 10.3390/pathogens12010051.